Biotechnology

Samsung Biologics to acquire PolyPeptide in $1.81bn cash deal

Samsung Biologics is set to acquire PolyPeptide Group through an all-cash public tender offer valued at SFr1.46bn ($1.81bn).

Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy

Harbour BioMed and Kelun-Biotech have received approval from China’s National Medical Products Administration (NMPA) for their investigational new drug (IND) application for the HBM7575/SKB575 bispecific antibody intended to treat asthma.

Innovent licenses IBI355 rights to Spero for up to $1.1bn

Innovent Biologics has agreed an exclusive licence deal worth up to $1.1bn with Spero Therapeutics, granting Spero the rights to develop, research, manufacture and commercialise IBI355, also known as SP001, outside Greater China.

Novartis and Chai Discovery collaborate on antibody identification

Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.

Takeda and Indonesia partner on plasma-derived therapies

Takeda and the Indonesian Government have announced a multi-phased collaboration to strengthen the country’s plasma ecosystem and expand access to plasma-derived medicinal products (PDMPs).

Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar

Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus (ocrelizumab) to treat multiple sclerosis (MS).

Immuno-oncology company Portage Biotech to evaluate strategic alternatives

Clinical-stage immuno-oncology company Portage Biotech has announced plans to expand its assessment of strategic alternatives.

AGC completes facility expansion for pDNA and mRNA production line

AGC Biologics has completed the facility expansion for its new plasmid DNA (pDNA) and messenger RNA (mRNA) production line at Heidelberg, Germany.

Chinese biotech firm Therorna closes $42m Series A financing round

China-based biotech company Therorna has secured $42m in a Series A financing round to support its growth and fuel product pipeline development.